Top segments and regional performance

Last year, the company generated ‪120.77 M‬ USD, the most of which — ‪120.77 M‬ USD — came from its top-performing segment, Therapeutics, compared to ‪128.94 M‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪120.77 M‬ USD last year, with ‪128.94 M‬ USD the year before.